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Background
Co-amoxiclav, a combination antibiotic consisting of
amoxicillin and clavulanic acid, is one of the most com-
monly prescribed anti-microbial drugs. Unfortunately,
human exposure is associated with liver injury and in rare
cases, acute liver failure has been reported. The risk of
liver injury appears be higher when amoxicillin/clavulanic
acid is used in combination. Little is known about the
mechanistic basis of co-amoxiclav-induced liver injury.
However, several HLA class I and II genotypes have
recently been shown to affect susceptibility, which indi-
cates a potential role for the adaptive immune system.
Thus, the objective of this study was to (1) investigate
whether drug responsive T-cells are detectable in the per-
ipheral blood of patients with co-amoxiclav-induced liver
injury, (2) define antigen specificity and (3) characterize
the phenotype and function of antigen-specific T-cells.
Method
The lymphocyte transformation test and IFN ELIspot were
used to detect drug responsive T-cells in the peripheral
blood of 7 patients with liver injury. T-cells were then
cloned to measure (1) proliferative responses in the pre-
sence of amoxicillin and clavulanic acid, (2) cell surface
marker expression by flow cytometry and (3) the profile of
secreted cytokines/cytolytic molecules by ELIspot.
Results
Lymphocytes from 5 out of 7 patients with co-amoxiclav-
induced liver injury were found to proliferate and/or
secrete IFN when cultured with amoxicillin or clavulanic
acid. Amoxicillin (n=78; CD4+ and CD8+) and clavulanic
acid (n=5; all CD4+) -responsive T-cell clones were gen-
erated by serial dilution. Activation of the clones was
drug-specific. Proliferative responses and IFN, IL13, FasL,
granzyme B and perforin secretion was detected with
amoxicillin or clavulanic acid, but not with the alterna-
tive antibiotic. Detailed structure activity studies using
the amoxicillin clones and 5 additional antibiotics identi-
fied T-cell responses against ampicillin alone.
Conclusion
These studies have characterized T-cells in the peripheral
blood of patients with co-amoxiclav-induced liver injury
that are selectively activated with either amoxicillin or
clavulanic acid. These data indicate that the adaptive
immune system participates in the disease pathogenesis.
Further work is needed to elucidate why amoxicillin,
when combined with clavulanic acid, is a common cause
of liver injury.
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